JD Health International Inc. (06618.HK) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	143.6B	73.4B	58.2B	53.5B	46.7B
Cost of Revenue	108.2B	55.2B	44.9B	41.7B	36.8B
Gross Profit	35.3B	18.2B	13.3B	11.9B	9.9B
Operating Expenses
R&D Expense	3.2B	1.6B	1.3B	1.2B	1.1B
SG&A Expense	25.1B	5.0B	4.5B	4.7B	4.3B
General & Admin Expense	1.9B	1.2B	1.4B	2.0B	2.2B
Selling & Marketing Expense	5.5B	3.8B	3.0B	2.7B	2.2B
Other Expenses	—	7.8B	6.3B	5.3B	82.5M
Total Operating Expenses	28.3B	14.4B	12.1B	11.2B	10.1B
Cost and Expenses	136.5B	69.6B	57.0B	52.9B	46.9B
Operating Income (EBIT)	7.0B	3.8B	1.2B	700.7M	(145.1M)
Non-Operating
Interest Income	3.1B	1.5B	2.0B	1.9B	864.3M
Interest Expense	15.4M	11.1M	8.2M	9.5M	9.1M
Net Interest Income	3.1B	1.5B	2.0B	1.9B	855.2M
Other Non-Op Income/Expense	5.5B	2.2B	3.6B	2.0B	742.7M
Non-Operating Income (excl Interest)	1.00	—	(3.3B)	(2.0B)	(751.8M)
EBT (Pre-Tax Income)	12.6B	6.0B	4.8B	2.7B	695.8M
Income Tax Expense	1.7B	662.9M	639.7M	550.5M	312.6M
Bottom Line
Net Income	10.9B	5.4B	4.2B	2.1B	380.1M
Earnings from Cont. Ops	10.9B	5.4B	4.2B	2.1B	383.2M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	10.9B	5.4B	4.2B	2.1B	380.1M
Per Share
Basic EPS	HK$3.40	HK$1.68	HK$1.32	HK$0.68	HK$0.12
Diluted EPS	HK$3.41	HK$1.68	HK$1.32	HK$0.68	HK$0.12
Revenue Per Share	HK$45.18	HK$22.98	HK$18.45	HK$16.99	HK$15.04
Shares
Basic Shares Outstanding	3.2B	3.2B	3.2B	3.1B	3.1B
Diluted Shares Outstanding	3.2B	3.2B	3.2B	3.2B	3.1B
Profitability Metrics
EBITDA	7.5B	4.0B	1.3B	2.9B	(60.9M)
D&A	470.2M	177.3M	152.0M	227.5M	140.7M
EBIT	7.0B	3.8B	1.2B	2.7B	704.9M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026